BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2005
View Archived Issues
Close proximity of dopaminergic and serotonergic neurons might explain delayed effects of SSRIs
Read More
Antidiabetic effects of cytogenin in streptozotocin-induced diabetes in mice
Read More
A novel Stat3 inhibitor as a treatment for breast cancer
Read More
Pregabalin provides fast pain relief in postherpetic neuralgia
Read More
Promising results obtained with a novel formulation of dronabinol in healthy volunteers
Read More
Japanese approval for Vfend
Read More
Delay to sBLA filing for Erbitux
Read More
Enrollment under way in SYNTAX trial comparing stents to cardiac surgery
Read More
Enrollment begins in ENDEAVOR IV study
Read More
Osel initiates two Lactin-V phase II studies
Read More
Memory extends timeline for safety and tolerability study of MEM-1003
Read More
Provectus prepares to study Xantryl in psoriasis and eczema
Read More
Series A financing to support Janus pipeline progression
Read More
OMS-103HP enters phase III
Read More
7TM Pharma and P&G sign research agreement
Read More
Enrollment completed in TRIUMPH study of eculizumab for PNH
Read More
Phase I/II trial begins for SonoLysis in PAOD
Read More
Seattle Genetics inlicenses anti-CD33 antibody program from PDL
Read More
Schering-Plough to begin preclinical development of collaborative compound
Read More
Vectura and Arakis sign development deal with Novartis for AD-237 for COPD
Read More
Alnylam and Benitec sign license agreement in RNAi
Read More
Development of a stable and effective vaginal anti-HIV microbicide
Read More
New family of non-nucleoside HCMV and VZV inhibitors
Read More
NGP-1-01, a promising lead for novel neuroprotective agents
Read More
5-HT2C agonists evaluated as therapeutics for urinary disorders
Read More
Pieris and Syngenta to develop Anticalins
Read More
Recent patents disclose new therapeutic agents for diabetes
Read More
Novel agents claimed for transplant rejection and immunological disorders
Read More
Japanese approval for Follistim
Read More
Raloxifene lowers the risk of cognitive impairment in postmenopausal women
Read More
